Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
2009; Springer Science+Business Media; Volume: 98; Issue: 1 Linguagem: Inglês
10.1007/s11060-009-0067-2
ISSN1573-7373
AutoresDavid M. Peereboom, Dale R. Shepard, Manmeet S. Ahluwalia, Cathy Brewer, Neeraj Agarwal, Glen Stevens, John H. Suh, Steven A. Toms, Michael A. Vogelbaum, Robert J. Weil, Paul Elson, Gene H. Barnett,
Tópico(s)Radiopharmaceutical Chemistry and Applications
Referência(s)